Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.

van Coevorden-Hameete MH, de Bruijn MAAM, de Graaff E, Bastiaansen DAEM, Schreurs MWJ, Demmers JAA, Ramberger M, Hulsenboom ESP, Nagtzaam MMP, Boukhrissi S, Veldink JH, Verschuuren JJGM, Hoogenraad CC, Sillevis Smitt PAE, Titulaer MJ.

Brain. 2019 Jun 1;142(6):1631-1643. doi: 10.1093/brain/awz094.

2.

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis.

de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH, Bastiaansen AEM, Schreurs MWJ, Rouhl RPW, van Donselaar CA, Majoie MHJM, Neuteboom RF, Sillevis Smitt PAE, Thijs RD, Titulaer MJ.

Neurology. 2019 May 7;92(19):e2185-e2196. doi: 10.1212/WNL.0000000000007475. Epub 2019 Apr 12.

3.

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.

Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2019 Jan 15;92(3):e244-e252. doi: 10.1212/WNL.0000000000006783. Epub 2018 Dec 21.

4.

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

Maddison P, Titulaer MJ, Verschuuren JJ, Gozzard P, Lang B, Irani SR, Sabater L, Graus F, Murray A, Chapman CJ.

J Neuroimmunol. 2019 Jan 15;326:14-18. doi: 10.1016/j.jneuroim.2018.11.003. Epub 2018 Nov 8.

5.

Predictive value of electroencephalography in anti-NMDA receptor encephalitis.

Sonderen AV, Arends S, Tavy DLJ, Bastiaansen AEM, Bruijn MAAM, Schreurs MWJ, Sillevis Smitt PAE, Titulaer MJ.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1101-1106. doi: 10.1136/jnnp-2018-318376. Epub 2018 Aug 22.

PMID:
30135187
6.

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis.

de Bruijn MAAM, Aarsen FK, van Oosterhout MP, van der Knoop MM, Catsman-Berrevoets CE, Schreurs MWJ, Bastiaansen DEM, Sillevis Smitt PAE, Neuteboom RF, Titulaer MJ; CHANCE Study Group.

Neurology. 2018 May 29;90(22):e1997-e2005. doi: 10.1212/WNL.0000000000005605. Epub 2018 Apr 27.

7.

Pruritus in anti-DPPX encephalitis.

Wijntjes J, Bechakra M, Schreurs MWJ, Jongen JLM, Koppenaal A, Titulaer MJ.

Neurol Neuroimmunol Neuroinflamm. 2018 Apr 2;5(3):e455. doi: 10.1212/NXI.0000000000000455. eCollection 2018 May. No abstract available.

8.

No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder.

Snijders G, Titulaer MJ, Bergink V, Bastiaansen AE, Schreurs MWJ, Ophoff RA, Boks MP, Kahn RS, de Witte LD.

Psychiatry Res. 2018 Jan;259:460-462. doi: 10.1016/j.psychres.2017.10.043. Epub 2017 Nov 2.

PMID:
29136601
9.

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes.

van Coevorden-Hameete MH, van Beuningen SFB, Perrenoud M, Will LM, Hulsenboom E, Demonet JF, Sabater L, Kros JM, Verschuuren JJGM, Titulaer MJ, de Graaff E, Sillevis Smitt PAE, Hoogenraad CC.

Ann Clin Transl Neurol. 2017 Jul 28;4(9):680-686. doi: 10.1002/acn3.396. eCollection 2017 Sep.

10.

Innate and adaptive immunity in human epilepsies.

Bauer J, Becker AJ, Elyaman W, Peltola J, Rüegg S, Titulaer MJ, Varley JA, Beghi E.

Epilepsia. 2017 Jul;58 Suppl 3:57-68. doi: 10.1111/epi.13784. Review.

11.

The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.

van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ.

Nat Rev Neurol. 2017 May;13(5):290-301. doi: 10.1038/nrneurol.2017.43. Epub 2017 Apr 18. Review.

PMID:
28418022
12.

DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

Hara M, Ariño H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2017 Apr 4;88(14):1340-1348. doi: 10.1212/WNL.0000000000003796. Epub 2017 Mar 3.

13.

Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).

Bastiaansen AEM, van Sonderen A, Titulaer MJ.

Curr Opin Neurol. 2017 Jun;30(3):302-309. doi: 10.1097/WCO.0000000000000444. Review.

PMID:
28248701
14.

Serum neuronal cell-surface antibodies in first-episode psychosis.

Leypoldt F, de Witte L, Lancaster E, Titulaer MJ.

Lancet Psychiatry. 2017 Mar;4(3):186-187. doi: 10.1016/S2215-0366(17)30043-3. No abstract available.

PMID:
28236946
15.

Nodding syndrome: Preventable and treatable.

Colebunders R, Titulaer MJ.

Sci Transl Med. 2017 Feb 15;9(377). pii: eaam8532. doi: 10.1126/scitranslmed.aam8532.

PMID:
28202778
16.

Author response: The clinical spectrum of Caspr2 antibody-associated disease.

van Sonderen A, Ariño H, Dalmau J, Titulaer MJ.

Neurology. 2017 Jan 17;88(3):333-334. doi: 10.1212/WNL.0000000000003526. No abstract available.

PMID:
28093513
17.

Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4.

van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, Wirtz PW, Schreurs MW, Claas FH, Sillevis Smitt PA, Titulaer MJ.

Ann Neurol. 2017 Feb;81(2):193-198. doi: 10.1002/ana.24858. Epub 2017 Jan 27.

PMID:
28026046
18.

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.

Lilleker JB, Jones MS, Mohanraj R, Yeo T, Chai JY, Tan K, van Sonderen A, Schreurs MW, de Bruijn MA, Sillevis Smitt PA, Titulaer MJ.

Neurology. 2016 Oct 25;87(17):1848-1849. No abstract available.

PMID:
27777346
19.

Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.

van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, van Coevorden-Hameete MH, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Titulaer MJ.

Neurology. 2016 Oct 4;87(14):1449-1456. Epub 2016 Sep 2.

PMID:
27590293
20.

From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.

van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ.

Autoimmun Rev. 2016 Oct;15(10):970-4. doi: 10.1016/j.autrev.2016.07.018. Epub 2016 Jul 30. Review.

21.

Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.

Planagumà J, Haselmann H, Mannara F, Petit-Pedrol M, Grünewald B, Aguilar E, Röpke L, Martín-García E, Titulaer MJ, Jercog P, Graus F, Maldonado R, Geis C, Dalmau J.

Ann Neurol. 2016 Sep;80(3):388-400. doi: 10.1002/ana.24721. Epub 2016 Aug 2.

22.

The clinical spectrum of Caspr2 antibody-associated disease.

van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917. Epub 2016 Jul 1.

23.

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System.

van Coevorden-Hameete MH, Titulaer MJ, Schreurs MW, de Graaff E, Sillevis Smitt PA, Hoogenraad CC.

Front Mol Neurosci. 2016 May 31;9:37. doi: 10.3389/fnmol.2016.00037. eCollection 2016. Review.

24.

Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.

Mitterreiter JG, Titulaer MJ, van Nierop GP, van Kampen JJ, Aron GI, Osterhaus AD, Verjans GM, Ouwendijk WJ.

PLoS One. 2016 May 12;11(5):e0155531. doi: 10.1371/journal.pone.0155531. eCollection 2016.

25.

Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies.

De Bruijn MA, Titulaer MJ.

Handb Clin Neurol. 2016;133:199-217. doi: 10.1016/B978-0-444-63432-0.00012-8.

PMID:
27112679
26.

The Association Between Atrophy and the Prognosis of Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Titulaer MJ.

JAMA Neurol. 2016 Jun 1;73(6):643-4. doi: 10.1001/jamaneurol.2016.0530. No abstract available.

PMID:
27110872
27.

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

Martinez-Hernandez E, Ariño H, McKeon A, Iizuka T, Titulaer MJ, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planagumà J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J.

JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.

28.

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.

van Sonderen A, Schreurs MW, de Bruijn MA, Boukhrissi S, Nagtzaam MM, Hulsenboom ES, Enting RH, Thijs RD, Wirtz PW, Sillevis Smitt PA, Titulaer MJ.

Neurology. 2016 May 3;86(18):1692-9. doi: 10.1212/WNL.0000000000002637. Epub 2016 Apr 1.

PMID:
27037230
29.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

30.

Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration.

van Coevorden-Hameete MH, de Graaff E, Titulaer MJ, Hulsenboom E, Sabater L, Hoogenraad CC, Sillevis Smitt PA.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e156. doi: 10.1212/NXI.0000000000000156. eCollection 2015 Oct. No abstract available.

31.

Early recognition of anti-N-methyl-D-aspartate receptor encephalitis in psychiatric patients.

van Mierlo HC, Titulaer MJ, Kromkamp M, van de Kraats R, van Veelen NM, Palmen SJ, Kahn RS, de Witte LD.

Acta Psychiatr Scand. 2015 Oct;132(4):312-3. doi: 10.1111/acps.12471. No abstract available.

PMID:
26371800
32.

Autoimmune Encephalitis in Postpartum Psychosis.

Bergink V, Armangue T, Titulaer MJ, Markx S, Dalmau J, Kushner SA.

Am J Psychiatry. 2015 Sep 1;172(9):901-8. doi: 10.1176/appi.ajp.2015.14101332. Epub 2015 Jul 17.

33.

Transient anti-NMDAR encephalitis in a newborn infant due to transplacental transmission.

Hilderink M, Titulaer MJ, Schreurs MW, Keizer K, Bunt JE.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 18;2(4):e126. doi: 10.1212/NXI.0000000000000126. eCollection 2015 Aug. No abstract available.

34.

Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J.

Neurology. 2015 Jun 16;84(24):2403-12. doi: 10.1212/WNL.0000000000001682. Epub 2015 May 15.

35.

Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies.

de Witte LD, Hoffmann C, van Mierlo HC, Titulaer MJ, Kahn RS, Martinez-Martinez P; European Consortium of Autoimmune Mental Disorders (CAIMED).

JAMA Psychiatry. 2015 Jul;72(7):731-3. doi: 10.1001/jamapsychiatry.2015.0526. No abstract available.

PMID:
25970159
36.

Fatal Balamuthia mandrillaris Meningoencephalitis in the Netherlands after Travel to The Gambia.

van der Beek NA, van Tienen C, de Haan JE, Roelfsema J, Wismans PJ, van Genderen PJ, Tanghe HL, Verdijk RM, Titulaer MJ, van Hellemond JJ.

Emerg Infect Dis. 2015 May;21(5):896-8. doi: 10.3201/eid2105.141325. No abstract available.

37.

Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.

Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J.

JAMA Neurol. 2015 Feb;72(2):180-6. doi: 10.1001/jamaneurol.2014.2956.

38.

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Planagumà J, Leypoldt F, Mannara F, Gutiérrez-Cuesta J, Martín-García E, Aguilar E, Titulaer MJ, Petit-Pedrol M, Jain A, Balice-Gordon R, Lakadamyali M, Graus F, Maldonado R, Dalmau J.

Brain. 2015 Jan;138(Pt 1):94-109. doi: 10.1093/brain/awu310. Epub 2014 Nov 11.

39.

Cortactin autoantibodies in myasthenia gravis.

Gallardo E, Martínez-Hernández E, Titulaer MJ, Huijbers MG, Martínez MA, Ramos A, Querol L, Díaz-Manera J, Rojas-García R, Hayworth CR, Verschuuren JJ, Balice-Gordon R, Dalmau J, Illa I.

Autoimmun Rev. 2014 Oct;13(10):1003-7. doi: 10.1016/j.autrev.2014.08.039. Epub 2014 Sep 3.

PMID:
25193850
40.

Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses.

Lancaster E, Leypoldt F, Titulaer MJ, Honnorat J, Waters PJ, Reindl M, Höftberger R.

Ann Neurol. 2015 Jan;77(1):183. doi: 10.1002/ana.24233. Epub 2014 Dec 4. No abstract available.

41.

Reply: To PMID 24700511.

Titulaer MJ, Rosenfeld MR, Dalmau J.

Ann Neurol. 2014 Sep;76(3):464-5. doi: 10.1002/ana.24223. Epub 2014 Jul 26. No abstract available.

PMID:
25043899
42.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J.

Ann Neurol. 2014 Mar;75(3):411-28.

43.

Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links.

Titulaer MJ, Dalmau J.

Mol Psychiatry. 2014 Oct;19(10):1054. doi: 10.1038/mp.2014.25. Epub 2014 Mar 25. No abstract available.

PMID:
24662926
44.

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, Ritacco DG, Grisold W, Meaney BF, Alcalá C, Sillevis-Smitt P, Titulaer MJ, Balice-Gordon R, Graus F, Dalmau J.

Lancet Neurol. 2014 Mar;13(3):276-86. doi: 10.1016/S1474-4422(13)70299-0. Epub 2014 Jan 22.

45.

Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis.

Titulaer MJ, Leypoldt F, Dalmau J.

Mov Disord. 2014 Jan;29(1):3-6. doi: 10.1002/mds.25716. Epub 2013 Nov 4. No abstract available.

46.

Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men.

Titulaer MJ, Dalmau J.

Neurology. 2014 Feb 18;82(7):550-1. doi: 10.1212/WNL.0000000000000131. Epub 2014 Jan 17. No abstract available.

PMID:
24443450
47.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J.

Lancet Neurol. 2014 Feb;13(2):167-77. doi: 10.1016/S1474-4422(13)70282-5. Epub 2013 Dec 18. Erratum in: Lancet Neurol. 2014 Feb;13(2):135.

48.

Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C, Pugh J, Vicente-Rasoamalala M, Lafuente-Hidalgo M, Macaya A, Ke M, Titulaer MJ, Höftberger R, Sheriff H, Glaser C, Dalmau J.

Ann Neurol. 2014 Feb;75(2):317-23. doi: 10.1002/ana.24083. Epub 2014 Feb 25.

49.

Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system.

van Coevorden-Hameete MH, de Graaff E, Titulaer MJ, Hoogenraad CC, Sillevis Smitt PA.

Autoimmun Rev. 2014 Mar;13(3):299-312. doi: 10.1016/j.autrev.2013.10.016. Epub 2013 Nov 10. Review.

PMID:
24225076
50.

Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report.

Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J.

Neurology. 2013 Oct 29;81(18):1637-9. doi: 10.1212/WNL.0b013e3182a9f531. Epub 2013 Oct 2. No abstract available.

Supplemental Content

Loading ...
Support Center